Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if GPCR is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
49 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 22 days ago
Red flags: 9
192 filers reported a long position in GPCR for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| FMR LLC | $419.2M | 7.8M | -7.1% |
| WELLINGTON MANAGEMENT GROUP LLP | $396.1M | 7.4M | +1.6% |
| Avoro Capital Advisors LLC | $351.8M | 6.6M | Unchanged |
| Jupiter Topco LLC | $279.3M | 5.2M | — |
| Deep Track Capital, LP | $254.4M | 4.7M | +10.8% |
| BVF INC/IL | $180.7M | 3.4M | -2.7% |
| MORGAN STANLEY | $150.6M | 2.8M | +21.7% |
| ORBIMED ADVISORS LLC | $118.6M | 2.2M | +49.7% |
| PRINCIPAL FINANCIAL GROUP INC | $94.1M | 1.8M | -0.1% |
| AMERICAN CENTURY COMPANIES INC | $90.3M | 1.7M | +17% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.